PACS Group (NYSE:PACS) Director Sells $214,085.60 in Stock

Posted by on Oct 30th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) Director Mark Hancock sold 4,280 shares of the stock in a transaction on Thursday, October 29th. The shares were sold at an average price of $50.02, for a total value of $214,085.60. Following the completion of the transaction, the director directly owned 53,505,580 shares in the company, valued at approximately $2,676,349,111.60. This trade represents a 0.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

  • On Wednesday, October 28th, Mark Hancock sold 9,024 shares of PACS Group stock. The shares were sold at an average price of $50.10, for a total value of $452,102.40.
  • On Tuesday, September 15th, Mark Hancock sold 155,682 shares of PACS Group stock. The stock was sold at an average price of $42.47, for a total value of $6,611,814.54.
  • On Monday, September 14th, Mark Hancock sold 144,318 shares of PACS Group stock. The stock was sold at an average price of $44.57, for a total value of $6,432,253.26.

PACS Group Trading Down 3.9%

Shares of NYSE:PACS traded down $1.92 during mid-day trading on Friday, reaching $47.76. The stock had a trading volume of 591,191 shares, compared to its average volume of 824,846. The firm has a 50 day simple moving average of $44.21 and a two-hundred day simple moving average of $39.79. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a market cap of $7.56 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 1.55 and a beta of -0.08. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $50.38.

PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. On average, research analysts predict that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Institutional Trading of PACS Group

A number of hedge funds have recently made changes to their positions in the business. Nisa Investment Advisors LLC boosted its stake in shares of PACS Group by 11.0% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock worth $97,000 after acquiring an additional 230 shares during the period. Financial Management Professionals Inc. raised its stake in PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after acquiring an additional 235 shares during the period. Jacobsen Capital Management raised its stake in PACS Group by 1.6% in the 1st quarter. Jacobsen Capital Management now owns 18,128 shares of the company’s stock valued at $582,000 after acquiring an additional 294 shares during the period. Smith Group Asset Management LLC raised its stake in PACS Group by 1.3% in the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after acquiring an additional 320 shares during the period. Finally, Toth Financial Advisory Corp lifted its holdings in PACS Group by 87.5% during the 3rd quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock valued at $62,000 after purchasing an additional 700 shares during the last quarter.

Analysts Set New Price Targets

PACS has been the subject of a number of recent research reports. Weiss Ratings upgraded shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. UBS Group upped their target price on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. increased their price objective on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Finally, Wall Street Zen cut shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $58.80.

Read Our Latest Report on PACS Group

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

Read More

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.